Plasma CRP Level and its Association with Outcome in Patients with Severe COVID-19 Pneumonia
DOI:
https://doi.org/10.3126/jucms.v10i01.47152Keywords:
COVID-19, CRP, SAR-COV-2, PneumoniaAbstract
INTRODUCTION
Corona virus disease 2019 (COVID-19) has become a global public health issue with unpredictable progression to ARDS. Therapy timing of anti-inflammatory agents and immune-suppressing medication is of utmost importance. Previous studies have consistently found elevated levels of C-Reactive Protein with disease severity. In this study, we aimed to investigate the relationship between C-Reactive Protein and severe SARS-COV-2 pneumonia.
MATERIAL AND METHODS
Our study included 55 patients with COVID-19, admitted in COVID Unit of Universal College of Medical Sciences Teaching Hospital (UCMS-TH), Bhairahawa, Rupendehi, Nepal from 16th June 2021 to 15th September 2021. We included COVID-19 cases confirmed by a RT-PCR test with severe pneumonia based on W.H.O criteria and those undergoing C-Reactive Protein levels.
RESULTS
Males (56%) were more compared to females (44%). Age group 41-60 years were likely to develop severe COVID-19 pneumonia. Cough (44%), dyspnea (42%) and fever (40%) were most common symptom. Hypertension (34%) and diabetis (24%) were common comorbidities present. Patients with severe COVID-19 pneumonia had average CRP value of 59.6 mg/l.
CONCLUSION
Elevated CRP level was associated with COVID-19 severity.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Universal College of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors have to give the following undertakings along with their article:
- I/we declare that this article is original and has not been submitted to another journal for publication.
- I/we declare that I/we surrender all the rights to the editor of the journal and if published will be the property of the journal and we will not publish it anywhere else, in full or part, without the permission of the Chief Editor.
- Institutional ethical and research committee clearance certificate from the institution where work/research was done, is required to be submitted.
- Articles in the Journal are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)
- This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.
